Login

Driving Ambition: Oxford Metrics features Chris Barnes, CEO of Tracsis Plc, segment by Cavendish 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
GV originated as an independent venture capital firm for innovative founders|Andy Wheeler,General Partner,GV
00:10:00
I'm Still Waiting For My Big Break|Talia Goldberg,Partner,Bessemer Venture Partners
00:10:00
The "Future of Fintech" video series, produced by Mobile Payments Today, features an interview on Galileo Securities.
00:10:00
Hassan Wahla, Telenav's Chief Commercial Officer, Delivers Insights on Autonomous Driving in Exclusive Interview | Telenav Inc
00:10:00
Calpeo Reports High-Grade Copper Results and Expands Mineralization at Lana Karina Project
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Creating a Private Equity Powerhouse: The Merger of Baring and EQT | Jean Salata, CEO, Baring Private Equity Asia Ltd.
00:10:00
Innovative PVD Coating Solutions for Hydrogen Applications | Stefan Dreger, President EMEA Hydrogen Solutions Impact Coatings
00:10:00
Samsara CEO Sanjit Biswas joins 'The Exchange' to discuss macro challenges in the operations industry and potential strategies.
00:10:00
Student Loan Planning for Medical Graduates | Tristan Crook, CERTIFIED FINANCIAL PLANNER of 308 Financial
00:10:00
Tiago Mafra's Vision for XP's Expansion and Impact | Thiago Maffra, CEO , XP Inc.
00:10:00
Digital Transformation Journey: Insights from Arbonia AG with Claudio Mettler | Michael Pieper - CEO of Arbonia AG

© 2026 Nehu